BOTOX® Cosmetic

Search documents
Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai
Prnewswire· 2025-09-25 09:00
Accessibility StatementSkip Navigation Allergan Aesthetics Global Medical Affairs Symposium on Skin Quality Multimodal MasteryA single- strategy treatment plan may not be enough to unlock the skin's full potential, and a multimodal approach is the focus of this year's medical symposium, 'Mastering Skin Quality - Integrating Aesthetic Modalities for Holistic Skin Quality Improvement' on Wednesday, 1 October at 2PM-4PM in Al Ameera Ballroom 2, Grand Hyatt Dubai. With 94% of people wanting to improve their fa ...
SkinMedica® Unveils Its Newest Hydration Hero
Prnewswire· 2025-08-19 12:00
Core Viewpoint - Allergan Aesthetics, a subsidiary of AbbVie, has launched the HA5® Hydra Collagen Hydrating Foaming Cleanser, which is designed to provide hydration and thorough cleansing for the skin, enhancing the effectiveness of subsequent skincare products [1][2]. Product Overview - The HA5® Hydra Collagen Hydrating Foaming Cleanser features the proprietary HA5® Hydra Collagen Complex, which includes five forms of hyaluronic acid and vegan hydra collagen, aimed at delivering instant hydration [1][2]. - The cleanser is formulated with 100% naturally derived amino acid-based surfactants and Pea Peptides, making it suitable for dry and sensitive skin [2]. - Clinical studies indicate that the cleanser can effectively remove makeup and impurities while boosting skin hydration by 30% when used with the HA5® Hydra Collagen Replenish + Restore Hydrator [2][3]. Market Positioning - Allergan Aesthetics emphasizes innovation in aesthetic medicine, positioning the HA5® line as a benchmark for advanced skin hydration solutions [2]. - The new cleanser is part of a broader portfolio that includes products from SkinMedica®, SKINVIVE by JUVÉDERM®, and DiamondGlow®, all aimed at providing superior hydration [2]. Expert Endorsement - Dr. Tiffany J. Libby, a board-certified dermatologist, endorses the product, highlighting its dual function of cleansing and hydrating while respecting the skin barrier [3]. Pricing and Availability - The HA5® Hydra Collagen Hydrating Foaming Cleanser is priced at $48 and is available for purchase on SkinMedica.com [3].
BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project
Prnewswire· 2025-07-22 12:00
IRVINE, Calif., July 22, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in The Confidence Project: Empowering Women Entrepreneurs. This initiative, led by BOTOX® Cosmetic, is aimed at closing the Confidence Gap and accelerating business growth for select entrepreneurs from across the country. Meet the Entrepreneurs: Introducing The Confidence Project's 2025 Class BOTOX® Cosmetic (onabotulinumtoxinA) Selects This ...
BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"
Prnewswire· 2025-05-01 21:00
Core Insights - Allergan Aesthetics, an AbbVie company, is launching "The Confidence Project" to empower women entrepreneurs and close the Confidence Gap [1][4][5] - The program invites business owners to apply for grants and mentorship opportunities, with applications open until May 9, 2025 [1][5] Program Details - The Confidence Project aims to support 250 women entrepreneurs this year, providing them with access to an intensive "Boostcamp" program that includes skill-building, mentorship, and networking [4][5] - Participants will have the opportunity to pitch their businesses for a chance to receive one of 20 grants worth $20,000 each [4][5] Financial Commitment - Since 2023, BOTOX® Cosmetic has allocated $1 million in grant funding to over 40 founders [4] - The initiative is part of a broader goal to empower 50,000 entrepreneurs by 2030 [7] Partnerships - The program is in partnership with Hello Alice, an online platform that assists businesses in launching and growing [4][5] - The collaboration aims to foster long-term growth and leadership among women in business [5]
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
Prnewswire· 2025-04-24 12:30
–TrenibotE is a first-in-class botulinum neurotoxin serotype E characterized by a rapid onset of action as early as 8 hours after administration (earliest assessment time) and shorter duration of effect of 2-3 weeks. –If approved, TrenibotE will be the first neurotoxin of its kind available to patients.–Submission is supported by data from over 2,100 patients treated with TrenibotE throughout the clinical program. NORTH CHICAGO, Ill., April 24, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced submis ...